NASDAQ:SWAV Shockwave Medical (SWAV) Stock Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free SWAV Stock Alerts $325.63 +3.02 (+0.94%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$322.61▼$331.5850-Day Range$217.19▼$325.6352-Week Range$157.00▼$331.58Volume814,172 shsAverage Volume698,070 shsMarket Capitalization$12.18 billionP/E Ratio84.14Dividend YieldN/APrice Target$271.44 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Shockwave Medical alerts: Email Address Shockwave Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.78 Rating ScoreUpside/Downside16.6% Downside$271.44 Price TargetShort InterestHealthy4.79% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment0.58Based on 31 Articles This WeekInsider TradingSelling Shares$28.34 M Sold Last QuarterProj. Earnings Growth25.77%From $4.89 to $6.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.24 out of 5 starsMedical Sector170th out of 938 stocksSurgical & Medical Instruments Industry18th out of 95 stocks 1.4 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $271.44, Shockwave Medical has a forecasted downside of 16.6% from its current price of $325.63.Amount of Analyst CoverageShockwave Medical has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.79% of the outstanding shares of Shockwave Medical have been sold short.Short Interest Ratio / Days to CoverShockwave Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shockwave Medical has recently increased by 5.29%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Shockwave Medical is -0.55. Previous Next 2.5 News and Social Media Coverage News SentimentShockwave Medical has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 31 news articles for Shockwave Medical this week, compared to 6 articles on an average week.Search InterestOnly 14 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of -22% compared to the previous 30 days.MarketBeat Follows12 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $28,337,059.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions95.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow by 25.77% in the coming year, from $4.89 to $6.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 84.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 84.14, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 241.39.Price to Earnings Growth RatioShockwave Medical has a PEG Ratio of 2.73. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 17.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> About Shockwave Medical Stock (NASDAQ:SWAV)Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More SWAV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SWAV Stock News HeadlinesMarch 28, 2024 | insidertrades.comLaura Francis Sells 1,500 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV) StockMarch 17, 2024 | insidertrades.comShockwave Medical, Inc. (NASDAQ:SWAV) Director Sells $507,300.00 in StockMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.March 29, 2024 | americanbankingnews.comIsaac Zacharias Sells 4,000 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV) StockMarch 29, 2024 | americanbankingnews.comShockwave Medical, Inc. (NASDAQ:SWAV) Director Sells $450,000.00 in StockMarch 28, 2024 | baystreet.caShockwave Medical Stock Rises Amid Johnson & Johnson Acquisition ReportsMarch 28, 2024 | americanbankingnews.comShockwave Medical (NASDAQ:SWAV) Now Covered by Analysts at CL KingMarch 27, 2024 | msn.comJ&J-Shockwave deal makes strategic sense: analystsMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.March 27, 2024 | msn.comJohnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says AnalystMarch 27, 2024 | finance.yahoo.comShockwave Medical Stock Sees Relative Strength Rating Ride HigherMarch 27, 2024 | wsj.comShockwave Medical Inc.March 27, 2024 | proactiveinvestors.comShockwave Medical rallies as J&J mulls purchaseMarch 27, 2024 | finance.yahoo.comThese Stocks Are Moving the Most Today: GameStop, Trump Media, Merck, Shockwave Medical, nCino, Carnival, and MoreMarch 27, 2024 | in.investing.comJohnson & Johnson considers deal for Shockwave Medical (SWAV) – WSJMarch 27, 2024 | msn.comWhat's Going On With Shockwave Medical Stock?March 27, 2024 | finance.yahoo.comShockwave Medical Stock Pops After Journal Reports Johnson & Johnson InterestMarch 27, 2024 | ca.finance.yahoo.comJ&J in talks to buy Shockwave Medical, WSJ reportsMarch 27, 2024 | finance.yahoo.comJohnson & Johnson Considers Deal for Shockwave MedicalMarch 27, 2024 | finance.yahoo.comJohnson & Johnson in talks to acquire Shockwave Medical: WSJMarch 26, 2024 | reuters.comJohnson & Johnson considers deal to buy Shockwave Medical, WSJ reportsMarch 26, 2024 | globenewswire.comShockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 22, 2024 | finance.yahoo.comDoes Shockwave Medical (SWAV) Have Strong Outlook for 2024?March 22, 2024 | americanbankingnews.comShockwave Medical (NASDAQ:SWAV) Shares Gap Up to $279.26March 15, 2024 | finance.yahoo.comCan Shockwave Medical, Inc. (NASDAQ:SWAV) Maintain Its Strong Returns?March 12, 2024 | finance.yahoo.comSWAV Apr 2024 135.000 putMarch 8, 2024 | finance.yahoo.comDirector Frank Watkins Sells 2,000 Shares of Shockwave Medical Inc (SWAV)See More Headlines Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/15/2024Today3/29/2024Next Earnings (Estimated)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,468Year FoundedN/APrice Target and Rating Average Stock Price Target$271.44 High Stock Price Target$368.00 Low Stock Price Target$210.00 Potential Upside/Downside-16.6%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$3.87 Trailing P/E Ratio84.14 Forward P/E Ratio66.59 P/E Growth2.73Net Income$147.28 million Net Margins20.17% Pretax Margin23.87% Return on Equity23.97% Return on Assets12.78% Debt Debt-to-Equity Ratio1.09 Current Ratio11.76 Quick Ratio10.73 Sales & Book Value Annual Sales$730.23 million Price / Sales16.68 Cash Flow$4.35 per share Price / Cash Flow74.80 Book Value$18.12 per share Price / Book17.97Miscellaneous Outstanding Shares37,400,000Free Float36,126,000Market Cap$12.18 billion OptionableOptionable Beta0.90 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Douglas E. Godshall M.B.A. (Age 59)President, CEO & Director Comp: $1.57MMr. Isaac Zacharias (Age 49)Chief Commercial Officer Comp: $908.02kMr. Daniel Hawkins (Age 57)Founder and Senior Advisor Mr. John M. Adams (Age 77)Co-Founder and Technical Advisor Ms. Renee M. Gaeta (Age 42)Chief Financial Officer Mr. Luis MoralesSenior Vice President of Global OperationsMs. Trinh Phung (Age 46)Chief Accounting Officer, Principal Accounting Officer & VP of Finance Ms. Debbie KasterVice President of Investor RelationsMr. Hajime Tada J.D.General Counsel & SecretaryMr. Robert FletcherSenior Vice President of Marketing & Market AccessMore ExecutivesKey CompetitorsTeleflexNYSE:TFXStevanato GroupNYSE:STVNPenumbraNYSE:PENGlobus MedicalNYSE:GMEDInspire Medical SystemsNYSE:INSPView All CompetitorsInsiders & InstitutionsIsaac ZachariasSold 4,000 sharesTotal: $1.15 M ($287.67/share)Laura FrancisSold 1,500 sharesTotal: $450,000.00 ($300.00/share)PNC Financial Services Group Inc.Bought 112 shares on 3/22/2024Ownership: 0.005%Vanguard Group Inc.Bought 33,539 shares on 3/11/2024Ownership: 9.716%Trinh PhungSold 21 sharesTotal: $5,315.94 ($253.14/share)View All Insider TransactionsView All Institutional Transactions SWAV Stock Analysis - Frequently Asked Questions Should I buy or sell Shockwave Medical stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SWAV shares. View SWAV analyst ratings or view top-rated stocks. What is Shockwave Medical's stock price target for 2024? 9 brokers have issued 12 month price objectives for Shockwave Medical's shares. Their SWAV share price targets range from $210.00 to $368.00. On average, they expect the company's share price to reach $271.44 in the next twelve months. This suggests that the stock has a possible downside of 16.6%. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts. How have SWAV shares performed in 2024? Shockwave Medical's stock was trading at $190.56 at the beginning of 2024. Since then, SWAV stock has increased by 70.9% and is now trading at $325.63. View the best growth stocks for 2024 here. When is Shockwave Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our SWAV earnings forecast. How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) issued its quarterly earnings data on Thursday, February, 15th. The company reported $1.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.24. The company earned $202.98 million during the quarter, compared to analysts' expectations of $199.43 million. Shockwave Medical had a net margin of 20.17% and a trailing twelve-month return on equity of 23.97%. Shockwave Medical's revenue for the quarter was up 41.0% compared to the same quarter last year. During the same period in the previous year, the business earned $3.71 earnings per share. What ETFs hold Shockwave Medical's stock? ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Neuberger Berman Disrupters ETF (NBDS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Alger Mid Cap 40 ETF (FRTY), WisdomTree U.S. Growth & Momentum Fund (WGRO) and First Trust Health Care AlphaDEX Fund (FXH). What guidance has Shockwave Medical issued on next quarter's earnings? Shockwave Medical issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $910.0 million-$930.0 million, compared to the consensus revenue estimate of $918.9 million. What is Doug Godshall's approval rating as Shockwave Medical's CEO? 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did Shockwave Medical IPO? Shockwave Medical (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. Who are Shockwave Medical's major shareholders? Shockwave Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.85%), Vanguard Group Inc. (9.72%), Wellington Management Group LLP (6.61%), Artisan Partners Limited Partnership (4.05%), Price T Rowe Associates Inc. MD (2.13%) and Price T Rowe Associates Inc. MD (2.13%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Frederic H Moll, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung. View institutional ownership trends. How do I buy shares of Shockwave Medical? Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SWAV) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.